We work at the interface of biology and engineering to develop new medical devices and human therapies. We create nanoparticles that can deliver genetic therapy inside of cells and even perform genome editing in vivo. We also develop living therapeutics, constructed from human cells and biomaterials, that can provide long-term therapy for chronic diseases like diabetes. Finally, we create smart biomaterials and responsive drug delivery systems that can integrate with the body and provide customized, on-demand treatment for patients.
Latest News
-
Emergency delivery of particulate drugs by active ejection using in vivo wireless devices
Implantable device could save diabetes patients from dangerously low blood sugar.
-
An immuno-invisibility cloak for implants
New class of copolymer coatings protect implants by regulating cellular adhesion and inflammation.
-
AI-guided design of LNPs for RNA delivery to lung
Deep-learning strategy identifies new ionizable lipids that achieve state-of-the-art mRNA delivery to lungs.